Dynamic, AI-driven healthcare access is inspired by the seamless and intuitive search experiences we've come to expect from ...

New findings suggest asthma may be reversible in some cases, offering hope for long-term remission and a shift in treatment ...

Niktimvo (axatilimab-csfr) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD ...

Imagine a radiologist examining a chest X-ray from a new patient. She notices the patient has swelling in the tissue but does ...